Table 1 Comparison of baseline and follow-up characteristics between HIV-infected patients with and without co-infection of tuberculosis in the unmatched sample with imputed covariates (for a single multiple imputation dataset)
Characteristics | TB: yes | TB: no | P-value | Standardized difference |
|---|---|---|---|---|
|  | (n = 1690) | (n = 20787) |  | (Ratio of variance for continuous covariate) |
Baseline characteristics | ||||
Demographics | ||||
Age (year) | Â | Â | Â | Â |
  Mean (SD) | 36.87 (8.78) | 37.93 (9.48) | <0.0001 | −0.117 (0.86) |
  Min | 14 | 14 | ||
  25th percentile | 31 | 31 | ||
  50th percentile | 36 | 37 | ||
  75th percentile | 42 | 43 | ||
  Max | 73 | 93 | ||
Male: n (%) | 670 (39.64) | 6216 (29.90) | <0.0001 | 0.206 |
HIV severity | ||||
CD4 count | Â | Â | Â | Â |
  Mean (SD) | 143.39 (149.94) | 170.82 (172.26) | <0.0001 | −0.170 (0.76) |
  Min | 0 | 0 | ||
  25th percentile | 45 | 66 | ||
  50th percentile | 111 | 139 | ||
  75th percentile | 193 | 208 | ||
  Max | 1701 | 1983 | ||
WHO stage: n (%) | Â | Â | Â | Â |
  1 | 43 (2.54) | 992 (4.77) | <0.0001 | - |
  2 | 441 (26.09) | 11013 (52.98) | ||
  3 | 999 (59.11) | 7173 (34.51) | ||
  4 | 207 (12.25) | 1609 (7.74) | ||
AIDS: n (%) | 493 (29.17) | 3881 (18.67) | <0.0001 | 0.248 |
History of drug use & illnesses: n (%) | ||||
Pneumocystis pneumonia | 28 (1.66) | 101 (0.49) | <0.0001 | 0.114 |
Toxoplasmosis | 11 (0.65) | 101 (0.49) | 0.3542 | 0.022 |
Sexually transmitted infection | 341 (20.17) | 4353 (20.94) | 0.4578 | −0.019 |
Partner information: n (%) | ||||
Married poly | 125 (7.40) | 1801 (8.66) | 0.0734 | −0.047 |
Partner sero-positive | 417 (24.67) | 5801 (27.91) | 0.0043 | −0.073 |
Sexually active | 1224 (72.43) | 15272 (73.47) | 0.3508 | −0.023 |
Other characteristics: n (%) | ||||
Site | Â | Â | Â | Â |
  ENT | 378 (22.37) | 1950 (9.38) | <0.0001 | - |
  GUL | 161 (9.53) | 1891 (9.10) | ||
  JIN | 276 (16.33) | 2586 (12.44) | ||
  MAS | 130 (7.69) | 2246 (10.80) | ||
  MBL | 144 (8.52) | 2446 (11.77) | ||
  MBR | 116 (6.86) | 2641 (12.71) | ||
  MSD | 61 (3.61) | 1254 (6.03) | ||
  MUL | 211 (12.49) | 2390 (11.50) | ||
  SOR | 29 (1.72) | 1546 (7.44) | ||
  TOR | 184 (10.89) | 1837 (8.84) | ||
Education (Higher institute) | 58 (3.43) | 623 (3.00) | 0.3158 | 0.025 |
ART start year since 2000 | Â | Â | Â | Â |
  0 | 0 (0) | 2 (0.01) | <0.0001 | - |
  4 | 23 (1.36) | 946 (4.55) | ||
  5 | 453 (26.80) | 4532 (21.80) | ||
  6 | 373 (22.07) | 3627 (17.45) | ||
  6 | 507 (30.00) | 6715 (32.30) | ||
  8 | 330 (19.53) | 4943 (23.78) | ||
  9 | 4 (0.24) | 22 (0.11) | ||
Follow-up characteristics | ||||
Death: n (%) | 177 (10.47) | 1326 (6.38) | <0.0001 | 0.148 |
Median (IQR) length of follow-up (days) | 627.5 (205–1034) | 646 (306–1045) | - | - |